# OnCo record viatris (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/viatris/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "viatris" ;
  schema:name "Viatris"@en ;
  schema:alternateName "Mylan"@en, "Mylan Inc."@en, "Mylan Pharmaceuticals Inc."@en, "Mylan N.V."@en, "Upjohn"@en ;
  schema:description "Viatris is the generics and biosimilars group formed in 2020 from Mylan and Pfizer's Upjohn; in cancer care it supplies generic chemotherapies and biosimilar trastuzumab and pegfilgrastim, and Mylan's phase 3 biosimilar trials sit under its name."@en ;
  schema:url <https://onco.cc/companies/viatris/>, <https://www.viatris.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.viatris.com>, <https://clinicaltrials.gov/search?lead=Mylan>, <https://www.wikidata.org/wiki/Q101983981> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:technologies <https://onco.cc/technologies/g-csf-growth-factors/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab-biosimilars/>, <https://onco.cc/drugs/pegfilgrastim/> ;
  onco:companies <https://onco.cc/companies/biocon-biologics/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/>, <https://onco.cc/terms/biosimilar/> .